Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis
Author(s) -
Claire ZarKessler,
Amel Karaa,
Katherine B. Sims,
Virginia Clarke,
Braden Kuo
Publication year - 2016
Publication title -
therapeutic advances in gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 51
eISSN - 1756-2848
pISSN - 1756-283X
DOI - 10.1177/1756283x16642936
Subject(s) - medicine , fabry disease , enzyme replacement therapy , disease , nausea , abdominal pain , gastrointestinal disease , diarrhea , gastrointestinal system , gastroparesis , gastrointestinal tract , vomiting , pediatrics , gastroenterology , intensive care medicine , dermatology , stomach , gastric emptying
Fabry disease is a rare X-linked lysosomal storage disease characterized by the dysfunction of multiple systems, including significant gastrointestinal involvement such as diarrhea, abdominal pain, early satiety and nausea. The gastrointestinal symptoms of Fabry disease are thought to be due to neuropathic and myopathic changes leading to symptoms of dysmotility that are encountered in many other disorders. The gastrointestinal symptoms can often be one of the presenting signs of the disease in childhood, but can be misdiagnosed by gastroenterologists for many years due to their nonspecific presentation. As the chief treatment for Fabry is enzyme-replacement therapy that has been shown to stabilize and possibly reverse disease course, recognition of these symptoms and early diagnosis in an attempt to prevent progression with treatment, is critical.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom